Amgen Inc.
GB ˙ BATS-CHIXE ˙ NL0000888691
SecurityGB:AMGD / Amgen Inc.
InstitutionModera Wealth Management, LLC
Latest Disclosed Ownership97,662 shares
Latest Disclosed Value $ 34,362,463
Modera Wealth Management, LLC reports 4.66% decrease in ownership of AMGD / Amgen Inc.

On May 6, 2026 - Modera Wealth Management, LLC filed a 13F-HR form disclosing ownership of 97,662 shares of Amgen Inc. (GB:AMGD) valued at $34,362,463 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 21, 2026 disclosing 102,431 shares of Amgen Inc.. This represents a change in shares of -4.66% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F AMGEN COM 031162100 97,662 -4,769 -4.66 34,362 2.49 0.4118
2026-01-21 2025-12-31 13F AMGEN COM 031162100 102,431 -2,080 -1.99 33,527 13.68 0.3878
2025-10-31 2025-09-30 13F AMGEN COM 031162100 104,511 -2,434 -2.28 29,493 -1.23 0.3417
2025-08-06 2025-06-30 13F AMGEN COM 031162100 106,945 -1,496 -1.38 29,860 -11.61 0.3697
2025-05-08 2025-03-31 13F AMGEN COM 031162100 108,441 -3,268 -2.93 33,785 16.04 0.4570
2025-02-06 2024-12-31 13F AMGEN COM 031162100 111,709 -1,499 -1.32 29,116 -20.18 0.3516
2024-10-24 2024-09-30 13F AMGEN COM 031162100 113,208 -7,796 -6.44 36,477 -3.52 0.4642
2024-07-29 2024-06-30 13F AMGEN COM 031162100 121,004 -5,872 -4.63 37,808 4.81 0.5570
2024-05-14 2024-03-31 13F AMGEN COM 031162100 126,876 -2,207 -1.71 36,073 -2.97 0.5494
2024-02-14 2023-12-31 13F AMGEN COM 031162100 129,083 -3,601 -2.71 37,179 4.26 0.6151
2023-11-30 2023-09-30 13F/A-1 AMGEN COM 031162100 132,684 -8,081 -5.74 35,660 14.10 0.6722
2023-11-01 2023-09-30 13F AMGEN COM 031162100 132,684 -8,081 35,660 0.6722
2023-08-07 2023-06-30 13F AMGEN COM 031162100 140,765 136,899 3,541.10 31,253 3,246.04 0.5674
2023-05-05 2023-03-31 13F AMGEN COM 031162100 3,866 -1,575 -28.95 935 -34.59 0.0363
2023-02-07 2022-12-31 13F AMGEN COM 031162100 5,441 -5 -0.09 1,429 16.38 0.0581
2022-11-01 2022-09-30 13F AMGEN COM 031162100 5,446 24 0.44 1,227 -6.97 0.0622
2022-07-27 2022-06-30 13F AMGEN COM 031162100 5,422 -14 -0.26 1,319 0.30 0.0628
2022-05-03 2022-03-31 13F AMGEN COM 031162100 5,436 121 2.28 1,315 9.95 0.0582
2022-02-04 2021-12-31 13F AMGEN COM 031162100 5,315 347 6.98 1,196 13.26 0.0457
2021-11-04 2021-09-30 13F AMGEN COM 031162100 4,968 -210 -4.06 1,056 -16.32 0.0542
2021-08-02 2021-06-30 13F AMGEN COM 031162100 5,178 127 2.51 1,262 0.40 0.0681
2021-04-29 2021-03-31 13F AMGEN COM 031162100 5,051 0 0.00 1,257 8.27 0.0817
2021-02-11 2020-12-31 13F AMGEN COM 031162100 5,051 3,318 191.46 1,161 163.86 0.0921
2020-11-12 2020-09-30 13F AMGEN COM 031162100 1,733 30 1.76 440 9.45 0.0653
2020-08-12 2020-06-30 13F AMGEN COM 031162100 1,703 -6 -0.35 402 16.18 0.0642
2020-05-12 2020-03-31 13F AMGEN COM 031162100 1,709 220 14.78 346 -3.62 0.0725
2020-02-05 2019-12-31 13F AMGEN COM 031162100 1,489 0 0.00 359 24.65 0.0561
2019-11-12 2019-09-30 13F AMGEN COM 031162100 1,489 -24,176 -94.20 288 -93.91 0.0479
2019-08-07 2019-06-30 13F AMGEN COM 031162100 25,665 2,239 9.56 4,730 6.29 0.8634
2019-05-13 2019-03-31 13F AMGEN COM 031162100 23,426 306 1.32 4,450 -1.13 0.8333
2019-02-14 2018-12-31 13F AMGEN COM 031162100 23,120 0 0.00 4,501 -6.09 0.8868
2018-11-09 2018-09-30 13F AMGEN COM 031162100 23,120 -5,170 -18.28 4,793 -8.22 0.9706
2018-08-09 2018-06-30 13F AMGEN COM 031162100 28,290 2,002 7.62 5,222 16.51 1.1006
2018-05-10 2018-03-31 13F AMGEN COM 031162100 26,288 36 0.14 4,482 -1.82 0.9297
2018-02-05 2017-12-31 13F AMGEN COM 031162100 26,252 331 1.28 4,565 -5.55 0.9841
2017-11-14 2017-09-30 13F Amgen COM 031162100 25,921 24,613 1,881.73 4,833 2,048.00 1.0889
2017-08-10 2017-06-30 13F AMGEN COM 031162100 1,308 1,308 225 0.0547
2016-05-16 2016-03-31 13F AMGEN COM 031162100 0 -1,362 -100.00 0 -100.00
2016-02-16 2015-12-31 13F AMGEN COM 031162100 1,362 1,362 221 0.0873
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.